Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
…, DR Jones, J Eckstein, K Ruterbories… - Drug Metabolism and …, 2002 - ASPET
… In general, K m orS 50 values for the substrates were 3 to 4 times lower for CYP3A4 than
for CYP3A5 or CYP3A7. For a more direct comparison of these P450 forms, clearance to the …
for CYP3A5 or CYP3A7. For a more direct comparison of these P450 forms, clearance to the …
The biotransformation of prasugrel, a new thienopyridine prodrug, by the human carboxylesterases 1 and 2
…, EJ Perkins, SA Wrighton, KJ Ruterbories… - Drug Metabolism and …, 2008 - ASPET
… Hydrolysis of prasugrel by hCE1 showed Michaelis-Menten kinetics yielding an apparent K
… At low concentrations, prasugrel hydrolysis by hCE2 yielded an apparent K s of 11.1 μM, an …
… At low concentrations, prasugrel hydrolysis by hCE2 yielded an apparent K s of 11.1 μM, an …
Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human
…, X Wang, H Wang, YW Qian, KJ Ruterbories… - Drug metabolism and …, 2011 - ASPET
… The substrate was 4-nitrophenyl butyrate at a concentration near the K m or K s value for
the hydrolysis of 4NPB by each CES (20 μM for dCES1, 40 μM for cCES1 and dCES2, and 90 …
the hydrolysis of 4NPB by each CES (20 μM for dCES1, 40 μM for cCES1 and dCES2, and 90 …
Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly …
MJ Zamek-Gliszczynski, KJ Ruterbories… - Journal of …, 2011 - Elsevier
Definitive plasma protein binding (PB) studies in drug development are routinely conducted
with radiolabeled material, where the radiochemical purity limits quantitative PB …
with radiolabeled material, where the radiochemical purity limits quantitative PB …
Determination of olanzapine in human blood by liquid chromatography–tandem mass spectrometry
M Berna, B Ackermann, K Ruterbories… - Journal of Chromatography …, 2002 - Elsevier
A liquid chromatographic–tandem mass spectrometric (LC–MS–MS) assay was developed
and validated to quantitatively determine olanzapine (OLZ) concentrations in human blood. …
and validated to quantitatively determine olanzapine (OLZ) concentrations in human blood. …
Integrity and efficiency: AbbVie's journey of building an integrated nonregulated bioanalytical laboratory
YT Wang, EM Maes, L Heinle, K Ruterbories, S Doktor… - Bioanalysis, 2023 - Future Science
… , K Desino, L Heinle, K Ruterbories and S Doktor made substantial contributions to the
conception or design of the work, the interpretation of data for the work and the drafting or revising …
conception or design of the work, the interpretation of data for the work and the drafting or revising …
Stereoselective metabolism of prasugrel in humans using a novel chiral liquid chromatography-tandem mass spectrometry method
ER Wickremsinhe, Y Tian, KJ Ruterbories… - Drug metabolism and …, 2007 - ASPET
A liquid chromatography-tandem mass spectrometry method was developed to chromatographically
separate the four stereoisomers of the active metabolite of prasugrel, R-138727, in …
separate the four stereoisomers of the active metabolite of prasugrel, R-138727, in …
Difference in the pharmacokinetics and hepatic metabolism of antidiabetic drugs in zucker diabetic fatty and sprague-dawley rats
…, NP Yumibe, LA Adams, KJ Ruterbories - Drug Metabolism and …, 2016 - ASPET
The Zucker diabetic fatty (ZDF) rat, an inbred strain of obese Zucker fatty rat, develops early
onset of insulin resistance and displays hyperglycemia and hyperlipidemia. The phenotypic …
onset of insulin resistance and displays hyperglycemia and hyperlipidemia. The phenotypic …
Chiral separation of neutral species by capillary electrophoresis evaluation of a theoretical model
S Surapaneni, K Ruterbories, T Lindstrom - Journal of Chromatography A, 1997 - Elsevier
A theoretical model has been developed for the separation of enantiomers of neutral species
by employing a combination of charged and neutral cyclodextrins. A neutral compound (…
by employing a combination of charged and neutral cyclodextrins. A neutral compound (…
Preclinical bridging studies: understanding dried blood spot and plasma exposure profiles
…, NH Huang, BG Abdul, K Knotts, KJ Ruterbories… - Bioanalysis, 2013 - Future Science
Background: Understanding the distribution of the analyte between the cellular and
noncellular (plasma) components of the blood is important, especially in situations where dried …
noncellular (plasma) components of the blood is important, especially in situations where dried …